Cargando…
Increased platelet reactivity in dyslipidemic patients with coronary artery disease on dual anti-platelet therapy
INTRODUCTION: The optimal duration of dual anti-platelet therapy (DAPT) following percutaneous coronary intervention (PCI) is still a matter of debate. Biomarkers may help to identify patients who will benefit from extended DAPT. The aim of the study was to test the interaction between lipid paramet...
Autores principales: | Jäger, Bernhard, Piackova, Editha, Haller, Paul Michael, Andric, Tijana, Kahl, Beatrice, Christ, Günther, Geppert, Alexander, Wojta, Johann, Huber, Kurt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348363/ https://www.ncbi.nlm.nih.gov/pubmed/30697254 http://dx.doi.org/10.5114/aoms.2018.81035 |
Ejemplares similares
-
The LIPL study: Postprandial lipid profile, inflammation, and platelet activity in patients with chronic coronary syndrome
por: Pogran, Edita, et al.
Publicado: (2023) -
Platelet Turnover Predicts Outcome after Coronary Intervention
por: Freynhofer, Matthias K., et al.
Publicado: (2017) -
Changes in Circulating Extracellular Vesicles in Patients with ST-Elevation Myocardial Infarction and Potential Effects of Remote Ischemic Conditioning—A Randomized Controlled Trial
por: Haller, Paul M., et al.
Publicado: (2020) -
Predictors of transportation delay in patients with suspected ST-elevation-myocardial infarction in the VIENNA-STEMI network
por: Jäger, Bernhard, et al.
Publicado: (2019) -
Platelets of patients with chronic kidney disease demonstrate deficient platelet reactivity in vitro
por: van Bladel, Esther R, et al.
Publicado: (2012)